# Section 204: Ketorolac

---

Ketorolac
Ketorolac
Mechanism of Action
Reversibly inhibits cyclooxygenase-1 and 2 (COX-1 and 2) enzymes, which results in decreased formation of prostaglandin precursors, has
antipyretic, analgesic and anti-inflammatory
Uses
Acute Pain
Contraindications
Hypersensitivity to ketorolac, aspirin and other NSAIDs, contraindicated during labor and delivery, active or history of peptic ulcer disease,
active or recent GI bleed. Ketorolac should not be administered to females of reproductive age without a documented negative pregnancy test.
This is due to harm that may be caused to a developing fetus, as well as potential bleeding complications in the Mother.
Elderly patients.
Patients with suspected intracranial hemorrhage, traumatic hemorrhage or anticipated emergent surgical intervention.
Protocol Uses
Pain Management – Adult (p58), Pain Management – Peds (p107)
Side Effects
CV: Edema, hypertension
EENT: Tinnitus
GI: GI pain, dyspepsia, nausea, diarrhea
Heme: Anemia, prolonged bleeding time, purpura
Skin: pruritus, diaphoresis
Pharmacokinetics
Onset IV 1 to 3 minutes, half-life elimination 5 hours, eliminated in the urine, crosses the placenta
Pregnancy Category – D
Interactions
Increase: effects of anticoagulants and other blood thinners (increased bleeding)
Increase: effects of ketorolac
Increase: effects of quinolones – neuroexcitatory and seizure potentiating
Decrease: effects of anti-hypertensives
EMT Considerations
Assess: Injection site of extravasation
Evaluate: Therapeutic response
Treatment of Overdose
Discontinue product, Supportive Care
Pharmaceuticals
~ This Space Intentionally Left Blank ~
215
B EMT
A A-EMT
P Paramedic
M Medical Control
EMR
